CN112136905A - 一种食用油 - Google Patents
一种食用油 Download PDFInfo
- Publication number
- CN112136905A CN112136905A CN202011036995.9A CN202011036995A CN112136905A CN 112136905 A CN112136905 A CN 112136905A CN 202011036995 A CN202011036995 A CN 202011036995A CN 112136905 A CN112136905 A CN 112136905A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- edible
- acid
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008157 edible vegetable oil Substances 0.000 title claims abstract description 48
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 70
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims abstract description 40
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 35
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 35
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 34
- 239000003921 oil Substances 0.000 claims abstract description 29
- 235000019198 oils Nutrition 0.000 claims abstract description 29
- 239000008169 grapeseed oil Substances 0.000 claims abstract description 21
- 235000019498 Walnut oil Nutrition 0.000 claims abstract description 20
- 235000021342 arachidonic acid Nutrition 0.000 claims abstract description 20
- 229940114079 arachidonic acid Drugs 0.000 claims abstract description 20
- 239000000944 linseed oil Substances 0.000 claims abstract description 20
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 20
- 239000008170 walnut oil Substances 0.000 claims abstract description 20
- 239000004006 olive oil Substances 0.000 claims abstract description 19
- 235000008390 olive oil Nutrition 0.000 claims abstract description 19
- 240000001548 Camellia japonica Species 0.000 claims abstract description 17
- 241000195493 Cryptophyta Species 0.000 claims abstract description 17
- 235000018597 common camellia Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000003755 preservative agent Substances 0.000 claims abstract description 11
- 230000002335 preservative effect Effects 0.000 claims abstract description 11
- 239000001387 apium graveolens Substances 0.000 claims description 13
- 244000124853 Perilla frutescens Species 0.000 claims description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 9
- 235000004347 Perilla Nutrition 0.000 claims description 9
- 241001122767 Theaceae Species 0.000 claims description 9
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 9
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 9
- 235000013824 polyphenols Nutrition 0.000 claims description 9
- 235000019155 vitamin A Nutrition 0.000 claims description 9
- 239000011719 vitamin A Substances 0.000 claims description 9
- 229940045997 vitamin a Drugs 0.000 claims description 9
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 5
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 5
- 235000020748 rosemary extract Nutrition 0.000 claims description 5
- 229940092258 rosemary extract Drugs 0.000 claims description 5
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 14
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000037208 balanced nutrition Effects 0.000 abstract description 2
- 235000019046 balanced nutrition Nutrition 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 3
- 201000006474 Brain Ischemia Diseases 0.000 description 3
- 206010008120 Cerebral ischaemia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000004626 essential fatty acids Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000021313 oleic acid Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 2
- 229940117893 apigenin Drugs 0.000 description 2
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 2
- 235000008714 apigenin Nutrition 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241000758789 Juglans Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001552 airway epithelial cell Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 230000001490 effect on brain Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000010460 hemp oil Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical class CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000004561 lacrimal apparatus Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003188 neurobehavioral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/06—Preservation of finished products
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本申请公开了一种食用油，包括以下重量份的原料：油茶籽油60‑100份，亚麻籽油10‑20份，核桃油20‑30份，葡萄籽油5‑10份，橄榄油5‑10份，DHA藻油3‑5份，花生四烯酸4‑6份，防腐剂0.5‑1.5份。该食用油营养均衡、安全性高、且易于吸收，能够满足婴幼儿、孕妇、以及中老年人等特殊人群的日常营养需求。
Description
技术领域
本发明涉及食用油技术领域，尤其涉及一种食用油。
背景技术
食用油是人们生活必需的消费品，是提供人体热能和必需脂肪酸，促进脂溶性维生素吸收的重要食物。在人类食物的诸多成分中，油脂作为生命能源的价值最高，其发热量为37.7KJ/g，高出蛋白质和碳水化合物一倍左右。随着中国经济的飞速发展，人民的生活水平大幅度提高，对食用油的质量要求也不断提升，其选择食用油的标准已不再停留在符合卫生、安全标准的层面上，而是更加注重食用油的健康、营养。
由于原料来源、加工工艺以及品质等原因，常见的食用油多为植物油脂，包括粟米油、菜籽油、花生油、火麻油、玉米油、橄榄油、山茶油、棕榈油、芥花子油、葵花子油、大豆油、芝麻油、亚麻籽油(胡麻油)、葡萄籽油、核桃油、牡丹籽油等等。每一种食用油都具有其营养特点，但单一品种的食用油营养功能结构不合理，其中所含的营养成分不够全面，无法满足特殊人群(如婴幼儿、孕妇、中老年人)的日常营养需求。
因此，如何提供一种营养均衡、利于吸收的食用油，成为了本领域技术人员亟待解决的技术问题。
发明内容
为了解决上述技术问题，本发明提供一种食用油，该食用油营养均衡、安全性高、且易于吸收，能够满足婴幼儿、孕妇、以及中老年人等特殊人群的日常营养需求。
本发明提供的一种食用油，包括以下重量份的原料：油茶籽油60-100份，亚麻籽油10-20份，核桃油20-30份，葡萄籽油5-10份，橄榄油5-10份，DHA藻油3-5份，花生四烯酸4-6份，防腐剂0.5-1.5份。
亚麻籽油由亚麻籽制取而成，亚麻籽油中α-亚麻酸含量为53％，α-亚麻酸是人体必需脂肪酸，具有抗肿瘤、抗血栓、降血脂、营养脑细胞、调节植物神经等作用，在人体内可转化为二十碳五烯酸和二十二碳六烯酸，长期食用能均衡营养,增进身体健康。
核桃油是采用核桃仁为原料，压榨而成的植物油。核桃油营养丰富、其不饱和脂肪酸含量≥92％，亚油酸Ω-6≥56％、亚麻酸Ω-3≥14％，富含天然VA、VD等营养物质。且酸度≤0.5，口感清淡无异味，脂肪酸组态近似母乳，易被消化吸收，是儿童发育期，女性妊娠期及产后康复的高级保健食用油。
葡萄籽油含有丰富的不饱和脂肪酸，主要是油酸和亚油酸，其中亚油酸的含量高达72％～76％。亚油酸是人体必需脂肪酸，易于被人体吸收，长期食用葡萄籽油可降低人体血清胆固醇，有效调节人的植物神经功能。葡萄籽油富含维生素E，具有较强的抗氧化性，能够有效地延长货架保质期，不易引起由于光照、热辐射和与空气接触而产生的氧化酸败现象。葡萄籽油中还含有人体必需的钾、钠、钙等矿物质及各种脂溶性及水溶性维生素，尤其适用于制作老人和婴幼儿营养品。
橄榄油富含丰富的单不饱和脂肪酸——油酸，还有维生素A、维生素B、维生素D、维生素E、维生素K及抗氧化物等。其所富含的单不饱和脂肪酸除能供给人体热能外，还能调整人体血浆中高、低密度脂蛋白胆固醇的比例，增加人体内的高密度脂蛋白HDL(好胆固醇)的水平和降低低密度脂蛋白LDL(坏胆固醇)水平，从而能防止人体内胆固醇过量。将橄榄油作为食用油使用，能有效的发挥其降血脂的功能，从而可以防止发生高血脂症、脂肪肝和保护心脏，有助于减少高血压病、冠心病、脑中风等富贵病的发生风险。
由于婴幼儿、孕妇及中老年人群体质的特殊性，他们所需要的不仅仅是油酸、亚油酸及α-亚麻酸，也需要添加长链多不饱和脂肪酸作为营养物质。
DHA俗称脑黄金，是一种对人体非常重要的多不饱和脂肪酸，属于Omega-3不饱和脂肪酸家族中的重要成员。DHA是神经系统细胞生长及维持的一种主要元素，是大脑和视网膜的重要构成脂肪酸，在人体大脑皮层中含量高达20％，在眼睛视网膜中所占比例最大，约占50％。对婴儿智力和视力发育至关重要。
花生四烯酸在血液、肝脏、肌肉和其他器官系统中作为磷脂结合的结构脂类起重要作用，它是许多循环二十烷酸衍生物的生物活性物质，如前列腺素E2(PGE2)、前列腺环素(PGI2)、血栓烷素A2(TXA2)和白细胞三烯和C4(LTC4)的直接前体。这些生物活性物质对脂质蛋白的代谢、血液流变学、血管弹性、白细胞功能和血小板激活等具有重要的调节作用。除此之外，花生四烯酸是人体大脑和视神经发育的重要物质，对提高智力和增强视敏度具有重要作用；其具有酯化胆固醇、增加血管弹性、降低血液粘度，调节血细胞功能等一系列生理活性；同时，花生四烯酸对预防心血管疾病、糖尿病和肿瘤等也具有重要功效。
DHA藻油和花生四烯酸的加入，能够使食用油的营养更加均衡，满足特殊人群的日常营养需求。
优选的，本发明提供的食用油，包括以下重量份的原料：油茶籽油70-90份，亚麻籽油12-16份，核桃油23-26份，葡萄籽油6-8份，橄榄油6-8份，DHA藻油3-5份，花生四烯酸4-6份，防腐剂0.5-1.5份。
作为优选，各原料的重量份分别为：油茶籽油78-82份，亚麻籽油12-16份，核桃油23-26份，葡萄籽油6-8份，橄榄油6-8份，DHA藻油4份，花生四烯酸5份，防腐剂0.8-1份。
优选的，所述防腐剂为茶多酚、迷迭香提取物、天然VE中的一种或几种。
茶多酚具有抗氧化、防辐射、抗衰老、降血脂、降血糖、抑菌抑酶等多种生理活性。迷迭香提取物具有抗氧化、抗癌、抗菌、抗病毒、抗炎、抗血栓、抗抑郁等作用。天然VE具有抗氧化、维持生育能力和调节免疫系统等诸多生物学功能。这三种天然抗氧化剂具有安全、环保、无毒、高效等特点，同时还具备多种生理功能，作为防腐剂加入食用油中，不仅能有效减缓食用油的氧化酸败、延长其货架期，而且可以预防人体多种疾病及亚健康状态的发生，避免合成抗氧化剂所带来的潜在食品安全问题。
优选的，本发明提供的食用油中，还包括0.1-1重量份的维生素A。
维生素A有促进生长、繁殖，维持骨骼、上皮组织、视力和粘膜上皮正常分泌等多种生理功能，维生素A及其类似物有阻止癌前期病变的作用。缺乏时表现为生长迟缓、暗适应能力减退而形成夜盲症。由于表皮和粘膜上皮细胞干燥、脱屑、过度角化、泪腺分泌减少，从而发生干眼病，重者角膜软化、穿孔而失明。呼吸道上皮细胞角化并失去纤毛，使抵抗力降低易于感染。
优选的，还包括3-5重量份的二十碳五烯酸。二十碳五烯酸的加入，能够补充植物油中所缺乏的长链多不饱和脂肪酸，使食用油的营养更加均衡。
优选的，还包括3-5重量份的芹菜籽油。
芹菜籽所含降压、降脂成分是芹菜的50倍，芹菜、芹菜籽油对脑衰老和脑缺血具有防治作用。研究表明，芹菜籽中油脂含量丰富，含有多种药理活性成分，具有散气、消肿、利尿、抗肿瘤及抗衰老等功效。文献报道芹菜甲素和芹菜乙素有延长小鼠戊巴比妥钠睡眠时间和广泛的抗惊厥作用，同时对脑细胞具有一定的保护作用。实验表明，芹菜籽油对脑缺血大鼠的脑指数和脑水肿有明显的改善作用。同时芹菜籽油能够改善MCAO大鼠的神经行为症状，减小脑梗塞的面积。表明芹菜籽油能够通过改善脑组织的缺血状态，减轻脑组织的缺血性损伤，达到抗脑缺血的作用。除此之外，芹菜籽精油对于表皮葡萄球菌、金黄色葡萄球菌和枯草芽孢杆菌等革兰氏阳性菌有较好的抑制作用，且其还具备较强的清除自由基抗氧化能力。
优选的，还包括5-10重量份的紫苏油。
紫苏籽油从唇形科药用植物紫苏的成熟的种籽获得，是一种高不饱和度的天然油脂，所含主要成份为α-亚麻酸，含量高达67％左右，是目前所发现的所有天然植物油中这种脂肪酸含量最高的。长期食用紫苏籽油能够增加脑部营养、健脑益智、调节脑神经和视神经功能；调节高血压、高血脂、降低胆固醇；防止动脉粥样硬化、抑制血栓形成；降低脑血栓及心血管病的发作；增强人体免疫功能；调节机体代谢、延缓机体衰老；减缓并防止老年痴呆症的发生；预防脂肪肝和糖尿病；对保健肌肤和减肥也有较好效果。
综上可知，本申请提供的食用油，以油茶籽油为基础成分，并配以亚麻籽油、核桃油、葡萄籽油、橄榄油、DHA藻油、和花生四烯酸6种成分，在保存了油茶籽油优良口感的同时，能够对食用油的营养成分起到均衡的效果。同时，防腐剂的加入，能够有效减缓食用油氧化酸败，延长其货架期。
具体实施方式
为了使本技术领域的人员更好地理解本申请中的技术方案，下面将结合具体的实施例，对本申请的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本申请的一部分实施例，而不是全部的实施例。基于本申请中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都应当属于本申请保护的范围。
实施例1
一种食用油，包括以下重量份的原料：油茶籽油60份，亚麻籽油10份，核桃油20份，葡萄籽油5份，橄榄油5份，DHA藻油3份，花生四烯酸4份，茶多酚0.5份。
实施例2
一种食用油，包括以下重量份的原料：油茶籽油100份，亚麻籽油20份，核桃油30份，葡萄籽油10份，橄榄油10份，DHA藻油5份，花生四烯酸6份，天然VE1.5份。
实施例3
一种食用油，包括以下重量份的原料：油茶籽油78份，亚麻籽油12份，核桃油23份，葡萄籽油6份，橄榄油6份，DHA藻油4份，花生四烯酸5份，迷迭香提取物0.8份，维生素A0.1份，芹菜籽油3份，紫苏油5份。
实施例4
一种食用油，包括以下重量份的原料：油茶籽油82份，亚麻籽油16份，核桃油26份，葡萄籽油8份，橄榄油8份，DHA藻油4份，花生四烯酸5份，茶多酚和天然VE共计1份，维生素A0.2份，二十碳五烯酸3份，芹菜籽油3份，紫苏油6份。
实施例5
一种食用油，包括以下重量份的原料：油茶籽油70份，亚麻籽油14份，核桃油24份，葡萄籽油7份，橄榄油7份，DHA藻油3份，花生四烯酸6份，茶多酚和天然VE共计1.5份，维生素A0.3份，芹菜籽油5份，紫苏油8份。
实施例6
一种食用油，包括以下重量份的原料：油茶籽油90份，亚麻籽油16份，核桃油26份，葡萄籽油8份，橄榄油8份，DHA藻油5份，花生四烯酸3份，茶多酚和天然VE共计0.6份，维生素A0.1份，芹菜籽油3份，紫苏油6份。
实施例7
一种食用油，包括以下重量份的原料：油茶籽油66份，亚麻籽油13份，核桃油24份，葡萄籽油9份，橄榄油8份，DHA藻油3.5份，花生四烯酸4.5份，茶多酚和迷迭香提取物共计1.1份，芹菜籽油5份，紫苏油10份。
实施例8
一种食用油，包括以下重量份的原料：油茶籽油95份，亚麻籽油11份，核桃油28份，葡萄籽油5份，橄榄油6份，DHA藻油5份，花生四烯酸5份，茶多酚和迷迭香提取物共计0.7份，紫苏油10份。
对所公开的实施例的上述说明，使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的，本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下，在其它实施例中实现。因此，本发明将不会被限制于本文所示的这些实施例，而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (8)
1.一种食用油，其特征在于，包括以下重量份的原料：油茶籽油60-100份，亚麻籽油10-20份，核桃油20-30份，葡萄籽油5-10份，橄榄油5-10份，DHA藻油3-5份，花生四烯酸4-6份，防腐剂0.5-1.5份。
2.根据权利要求1所述的食用油，其特征在于，包括以下重量份的原料：油茶籽油70-90份，亚麻籽油12-16份，核桃油23-26份，葡萄籽油6-8份，橄榄油6-8份，DHA藻油3-5份，花生四烯酸4-6份，防腐剂0.5-1.5份。
3.根据权利要求2所述的食用油，其特征在于，包括以下重量份的原料：油茶籽油78-82份，亚麻籽油12-16份，核桃油23-26份，葡萄籽油6-8份，橄榄油6-8份，DHA藻油4份，花生四烯酸5份，防腐剂0.8-1份。
4.根据权利要求1至3任一项所述的食用油，其特征在于，所述防腐剂为茶多酚、迷迭香提取物、天然VE中的一种或几种。
5.根据权利要求4所述的食用油，其特征在于，还包括0.1-1重量份的维生素A。
6.根据权利要求4所述的食用油，其特征在于，还包括3-5重量份的二十碳五烯酸。
7.根据权利要求5或6所述的食用油，其特征在于，还包括3-5重量份的芹菜籽油。
8.根据权利要求7所述的食用油，其特征在于，还包括5-10重量份的紫苏油。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011036995.9A CN112136905A (zh) | 2020-09-27 | 2020-09-27 | 一种食用油 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011036995.9A CN112136905A (zh) | 2020-09-27 | 2020-09-27 | 一种食用油 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112136905A true CN112136905A (zh) | 2020-12-29 |
Family
ID=73895611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011036995.9A Pending CN112136905A (zh) | 2020-09-27 | 2020-09-27 | 一种食用油 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112136905A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102132742A (zh) * | 2010-12-29 | 2011-07-27 | 九三粮油工业集团有限公司 | 一种具有益智功效的食用营养油 |
| CN102239933A (zh) * | 2011-06-23 | 2011-11-16 | 中国农业科学院油料作物研究所 | 一种家庭平衡配方油及其制备方法 |
| CN104719510A (zh) * | 2015-03-20 | 2015-06-24 | 湖南洋膳科技有限公司 | 含dha和aa的孕妇婴幼儿营养茶油 |
| CN107361158A (zh) * | 2017-08-25 | 2017-11-21 | 油谷生物科技南京有限公司 | 一种营养油及其制备和应用 |
| CN107509822A (zh) * | 2017-08-25 | 2017-12-26 | 山东鲁派国际食品有限公司 | 一种孕妇专用食用油及其制备方法 |
| CN111567632A (zh) * | 2020-06-08 | 2020-08-25 | 付斌 | 一种膳食脂肪酸营养平衡调和油及制备方法 |
-
2020
- 2020-09-27 CN CN202011036995.9A patent/CN112136905A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102132742A (zh) * | 2010-12-29 | 2011-07-27 | 九三粮油工业集团有限公司 | 一种具有益智功效的食用营养油 |
| CN102239933A (zh) * | 2011-06-23 | 2011-11-16 | 中国农业科学院油料作物研究所 | 一种家庭平衡配方油及其制备方法 |
| CN104719510A (zh) * | 2015-03-20 | 2015-06-24 | 湖南洋膳科技有限公司 | 含dha和aa的孕妇婴幼儿营养茶油 |
| CN107361158A (zh) * | 2017-08-25 | 2017-11-21 | 油谷生物科技南京有限公司 | 一种营养油及其制备和应用 |
| CN107509822A (zh) * | 2017-08-25 | 2017-12-26 | 山东鲁派国际食品有限公司 | 一种孕妇专用食用油及其制备方法 |
| CN111567632A (zh) * | 2020-06-08 | 2020-08-25 | 付斌 | 一种膳食脂肪酸营养平衡调和油及制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 唐春红，: "《天然防腐剂与抗氧化剂》", 31 May 2010, 中国轻工业出版社 * |
| 罗质，: "《油脂精炼工艺学》", 30 June 2016, 中国轻工业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zielińska et al. | Abundance of active ingredients in sea-buckthorn oil | |
| Marcinek et al. | Chia seeds (Salvia hispanica): health promoting properties and therapeutic applications-a review | |
| CN103444911A (zh) | 一种药食同源养生保健调和油 | |
| CN100562254C (zh) | 一种植物调和油 | |
| EP1876906B1 (de) | Nahrungsergänzungsmittel oder functional food enthaltend öl-kombination | |
| CN108720021A (zh) | Dha藻油微胶囊粉末及其制备方法 | |
| CN101720822A (zh) | 一种脂肪酸组分平衡并含有活性成分的中老年型营养调和油 | |
| CN101810226A (zh) | 一种脂肪酸组分平衡并含有多种活性成分的儿童型营养调和油 | |
| CN1806642A (zh) | 一种营养保健植物调和油 | |
| CN105707292A (zh) | 一种适用于婴幼儿的山茶调和油 | |
| CN103380826A (zh) | 一种具有预防心脑血管疾病风险因子作用的功能性油脂及其制备方法 | |
| US20180042978A1 (en) | Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus | |
| CN103082034A (zh) | 一种保健调和油 | |
| WO2003056939A1 (en) | Oil blends | |
| CN103651949A (zh) | 一种养生减肥型调和油 | |
| Oboulbiga et al. | Physicochemical, potential nutritional, antioxidant and health properties of sesame seed oil: a review | |
| KR100724165B1 (ko) | 식품 성분으로서 비비누화물이 농축된 천연 식물성유 | |
| CN112136905A (zh) | 一种食用油 | |
| CN108094575A (zh) | 一种含有牡丹籽油的食用油及其制备方法 | |
| CN108782786B (zh) | 一种黑蒜健康食用调和油及其制备方法 | |
| CN106260120B (zh) | 一种富硒食用调和油及其制备方法 | |
| Lee | Essent ial Fat ty Acids | |
| CN103766507A (zh) | 一种具有保健功能的食用油 | |
| CN107183219A (zh) | 一种低温营养调和油及其制备方法 | |
| Shrestha et al. | Chemical Composition, Health Benefits and Applications of Chia seeds: A Review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201229 |
|
| RJ01 | Rejection of invention patent application after publication |